LifeMD (LFMD) Equity Average (2013 - 2025)

LifeMD has reported Equity Average for 13 years, with the latest figure at $13.3 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average rose 287.05% year-over-year to $13.3 million; the trailing twelve-month figure through Dec 2025 stood at $13.3 million (up 287.05% YoY), and the FY2025 full-year result was $7.0 million, up 387.55% from the prior year.
• Equity Average for Q4 2025 stood at $13.3 million, up from -$119.9 million in the prior quarter.
• The five-year high for Equity Average was $16.9 million in Q1 2022, with the low at -$120.6 million in Q2 2025.
• Historically, Equity Average has averaged -$14.0 million across 5 years, with a median of -$3.5 million in 2024.
• Annual changes were most pronounced in 2022 — Equity Average soared 736.21% — and 2025, when it sank 48209.02%.
• LifeMD's Equity Average stood at $1.5 million in 2021, then sank by 534.11% to -$6.6 million in 2022, then soared by 47.92% to -$3.4 million in 2023, then plunged by 105.66% to -$7.1 million in 2024, then surged by 287.05% to $13.3 million in 2025.
• The last three Equity Average figures came in at $13.3 million (Q4 2025), -$119.9 million (Q3 2025), and -$120.6 million (Q2 2025), per Business Quant data.